Pharsight

Nextwave Pharms patents expiration

1. Quillichew Er patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8202537 NEXTWAVE PHARMS Modified release formulations containing drug-ion exchange resin complexes
Mar, 2027

(2 years from now)

US8287903 NEXTWAVE PHARMS Orally effective methylphenidate extended release powder and aqueous suspension product
Feb, 2031

(6 years from now)

US9545399 NEXTWAVE PHARMS Methylphenidate extended release chewable tablet
Aug, 2033

(9 years from now)

US9295642 NEXTWAVE PHARMS Methylphenidate extended release chewable tablet
Aug, 2033

(9 years from now)

US9844544 NEXTWAVE PHARMS Methylphenidate extended release chewable tablet
Aug, 2033

(9 years from now)

US10857143 NEXTWAVE PHARMS Methylphenidate extended release chewable tablet
Aug, 2033

(9 years from now)

US11103495 NEXTWAVE PHARMS Methylphenidate extended release chewable tablet
Aug, 2033

(9 years from now)

US11103494 NEXTWAVE PHARMS Methylphenidate extended release chewable tablet
Aug, 2033

(9 years from now)

US8999386 NEXTWAVE PHARMS Methylphenidate extended release chewable tablet
Aug, 2033

(9 years from now)

US11633389 NEXTWAVE PHARMS Methylphenidate extended release chewable tablet
Aug, 2033

(9 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Dec 04, 2018

Drugs and Companies using METHYLPHENIDATE HYDROCHLORIDE ingredient

Market Authorisation Date: 04 December, 2015

Treatment: A method of providing a subject with therapeutically effective amount of racemic methylphenidate by orally administering to said subject a single methylphenidate extended release chewable tablet accor...

Dosage: TABLET, EXTENDED RELEASE, CHEWABLE;ORAL

How can I launch a generic of QUILLICHEW ER before it's drug patent expiration?
More Information on Dosage

QUILLICHEW ER family patents

Family Patents